Awiqli 1050 Unit (Insulin Icodec SOLUTION) 1050 UNIT

Awiqli 1050 Unit is an insulin analog used to manage blood glucose levels in diabetes. It is indicated for the following conditions:

• Type 1 diabetes mellitus: Helps manage blood glucose levels in adults who require long-acting insulin.
• Type 2 diabetes mellitus: Used as part of a comprehensive treatment plan to control blood sugar levels in adults.
• Long-acting insulin requirement: Provides steady glucose-lowering coverage over a week, reducing the need for daily injections.

• Insulin icodec, the active ingredient in Awiqli 1050 Unit, binds to insulin receptors in the body, stimulating glucose uptake and utilization. This process helps lower blood glucose levels by facilitating the movement of glucose from the blood into muscles and other tissues where it can be used for energy. It also reduces the amount of sugar produced by the liver, contributing to overall glycemic control.

Awiqli 1050 Unit, like other insulin products, can cause side effects. Common side effects include:

Common Side Effects

• Low blood sugar (hypoglycemia): Symptoms may include sweating, tiredness, trembling, and weakness.
• Weight gain: Some users may experience an increase in body weight.
• Injection site reactions: Pain, itching, or swelling at the injection site.
• Unusual tiredness: Feeling more fatigued than usual.
• Muscle cramps or twitching: May occur as a result of low blood sugar.
• Constipation: Some users may experience digestive issues.

Serious or Rare Side Effects

• Severe hypoglycemia: Can be life-threatening if not treated promptly.
• Allergic reactions: Symptoms may include rash, itching, or difficulty breathing.
• Swelling in the arms or legs: May indicate fluid retention.
• Severe weakness: Can be a sign of significant low blood sugar or other underlying issues.

Awiqli 1050 Unit should be used with caution and under the guidance of a healthcare professional. Important precautions include:

• Dosage adjustment: Your dose should be determined by your doctor based on your blood glucose levels and other factors.
• Monitoring blood sugar: Regularly check your blood sugar levels to avoid hypoglycemia or hyperglycemia.
• Diet and exercise: Maintain a balanced diet and regular exercise regimen as part of your diabetes management plan.
• Medication changes: Inform your healthcare provider about any changes in your medication, diet, or exercise routine.
• Hypoglycemia management: Be prepared to treat low blood sugar episodes with fast-acting carbohydrates.
• Storage: Store unopened Awiqli pens in the refrigerator between 36°F and 46°F (2°C and 8°C) until the expiration date. Do not freeze or place it near the cooling element in the fridge. Once opened, store at room temperature or in the refrigerator, but do not use beyond 12 weeks after opening. Protect from light and moisture, and keep out of the reach of children.

Awiqli 1050 Unit may interact with other medications, potentially affecting its efficacy or increasing the risk of side effects. Major and moderate interactions include:

Major Interactions (Avoid)

• Other insulin products: Avoid using Awiqli with other insulin products unless specifically instructed by your healthcare provider.
• Oral hypoglycemic agents: Combining Awiqli with other blood sugar-lowering medications may increase the risk of hypoglycemia.
• Corticosteroids: May reduce the effectiveness of Awiqli, leading to higher blood sugar levels.
• Diuretics: Can affect blood sugar levels and may require dosage adjustments.
• Beta-blockers: May mask symptoms of hypoglycemia, making it harder to recognize low blood sugar.

Moderate Interactions (Monitor Closely)

• Antipsychotics: May affect blood sugar levels and require close monitoring.
• Oral contraceptives: May influence blood sugar control and necessitate dosage adjustments.
• Thyroid medications: Can impact blood sugar levels and may need to be monitored closely.
• Antidepressants: May affect blood sugar levels and require regular monitoring.